Characterization of Distinct T Cell Receptor Repertoires in Tumor and Distant Non-tumor Tissues from Lung Cancer Patients
Open Access
- 1 June 2019
- journal article
- research article
- Published by Oxford University Press (OUP) in Genomics, Proteomics & Bioinformatics
- Vol. 17 (3) , 287-296
Abstract
T cells and T cell receptors (TCRs) play pivotal roles in adaptive immune responses against tumors. The development of next-generation sequencing technologies has enabled the analysis of the TCRβ repertoire usage. Given the scarce investigations on the TCR repertoire in lung cancer tissues, in this study, we analyzed TCRβ repertoires in lung cancer tissues and the matched distant non-tumor lung tissues (normal lung tissues) from 15 lung cancer patients. Based on our results, the general distribution of T cell clones was similar between cancer tissues and normal lung tissues; however, the proportion of highly expanded clones was significantly higher in normal lung tissues than in cancer tissues (0.021% ± 0.002% vs. 0.016% ± 0.001%, P = 0.0054, Wilcoxon signed rank test). In addition, a significantly higher TCR diversity was observed in cancer tissues than in normal lung tissues (431.37 ± 305.96 vs. 166.20 ± 101.58, P = 0.0075, Mann-Whitney U test). Moreover, younger patients had a significantly higher TCR diversity than older patients (640.7 ± 295.3 vs. 291.8 ± 233.6, P = 0.036, Mann-Whitney U test), and the higher TCR diversity in tumors was significantly associated with worse cancer outcomes. Thus, we provided a comprehensive comparison of the TCR repertoires between cancer tissues and matched normal lung tissues and demonstrated the presence of distinct T cell immune microenvironments in lung cancer patients.Keywords
Funding Information
- CAMS Innovation Fund for Medical Sciences (2016-I2M-1-001)
- National Key Research and Development Program of China (2017YFC0908401)
- National Basic Research Program of China (2014CBA02004)
- CAMS Innovation Fund for Medical Sciences (2016-I2M-1-001)
- National key research and development program (2017YFC0908401)
- National Basic Research Program (2014CBA02004)
This publication has 33 references indexed in Scilit:
- T cell receptor repertoire usage in cancer as a surrogate marker for immune responsesSeminars in Immunopathology, 2017
- Diversity and divergence of the glioma-infiltrating T-cell receptor repertoireProceedings of the National Academy of Sciences, 2016
- Characteristics of Tumor Infiltrating Lymphocyte and Circulating Lymphocyte Repertoires in Pancreatic Cancer by the Sequencing of T Cell ReceptorsScientific Reports, 2015
- Immunosequencing: applications of immune repertoire deep sequencingCurrent Opinion in Immunology, 2013
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion SequencingNew England Journal of Medicine, 2012
- The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysisBritish Journal of Cancer, 2011
- Recombination centres and the orchestration of V(D)J recombinationNature Reviews Immunology, 2011
- Exhaustive T-cell repertoire sequencing of human peripheral blood samples reveals signatures of antigen selection and a directly measured repertoire size of at least 1 million clonotypesGenome Research, 2011
- Functional Development of the T Cell Receptor for Antigen2010
- Somatic generation of antibody diversityNature, 1983